SCHEMBL6345281

SCHEMBL6345281

COC(=O)c1cccc2[nH]c3c(c(C)nn3-c3ccccn3)c(=O)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 5/20 0.46
HPGD P15428 5/20 0.46
MAPT P10636 4/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
THRB P10828 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
GAA P10253 2/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TSHR P16473 2/20 0.40
USP2 O75604 1/20 0.40
SPR P35270 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6340217 0.89 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL6351972 0.83 MAPT (0.41) ALDH1A1KDM4EHPGDMAPTTHRB
SCHEMBL6354124 0.82 MAPT (0.41) ALDH1A1KDM4EHPGDMAPTTHRB
SCHEMBL6340087 0.81 MAPT (0.42) ALDH1A1KDM4EHPGDMAPTTHRB
SCHEMBL6340214 0.80 DYRK1A (0.47) ALDH1A1KDM4EHPGDMAPTGAA
SCHEMBL6350724 0.80 KDM4E (0.44) ALDH1A1KDM4EHPGDMAPTCYP1A2
Hydrochloric Acid SCHEMBL6342923 0.80 MAPT (0.42) ALDH1A1KDM4EHPGDMAPTTHRB
SCHEMBL6339985 0.78 L3MBTL1 (0.43) ALDH1A1HPGDMAPTTHRBTDP1
SCHEMBL6350627 0.76 ADORA3 (0.44) ALDH1A1KDM4EHPGDMAPTCYP1A2
SCHEMBL6350635 0.76 MAPT (0.39) ALDH1A1KDM4EHPGDMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 ALDH1A1 1061/4885KDM4E 1741/4885HPGD 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.